Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manon C Spaander

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Digestive Diseases and Sciences|June 16, 2018
Natural History of Barrett's EsophagusErnst J Kuipers, Manon C Spaander
Best Practice & Research. Clinical Gastroenterology|March 7, 2015
Acid suppression and surgical therapy for Barrett's oesophagusPieter J F de Jonge, Manon C Spaander, Marco J Bruno, et al.
Medicine|November 29, 2016
Value of cyclin A immunohistochemistry for cancer risk stratification in Barrett esophagus surveillance: A multicenter case-control studySophie H van Olphen, Fiebo J C Ten Kate, Michail Doukas, et al.
Gastroenterology|December 19, 2016
Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index EndoscopyPrashanthi N Thota, Prashanth Vennalaganti, Sreekar Vennelaganti, et al.
Eclinicalmedicine|January 26, 2026
Pancreatic cancer risk and survival in patients with Lynch syndrome: a nationwide Dutch cohort studyAleksander M Bogdanski, Derk C F Klatte, Bert A Bonsing, et al.
Gastroenterology|December 3, 2014
Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagusClaire Palles, Laura Chegwidden, Xinzhong Li, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Digestive Diseases and Sciences|June 16, 2018
Natural History of Barrett's EsophagusErnst J Kuipers, Manon C Spaander
Best Practice & Research. Clinical Gastroenterology|March 7, 2015
Acid suppression and surgical therapy for Barrett's oesophagusPieter J F de Jonge, Manon C Spaander, Marco J Bruno, et al.
Medicine|November 29, 2016
Value of cyclin A immunohistochemistry for cancer risk stratification in Barrett esophagus surveillance: A multicenter case-control studySophie H van Olphen, Fiebo J C Ten Kate, Michail Doukas, et al.
Gastroenterology|December 19, 2016
Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index EndoscopyPrashanthi N Thota, Prashanth Vennalaganti, Sreekar Vennelaganti, et al.
Eclinicalmedicine|January 26, 2026
Pancreatic cancer risk and survival in patients with Lynch syndrome: a nationwide Dutch cohort studyAleksander M Bogdanski, Derk C F Klatte, Bert A Bonsing, et al.
Gastroenterology|December 3, 2014
Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagusClaire Palles, Laura Chegwidden, Xinzhong Li, et al.
Pageof 1